Aurinia Pharmaceuticals Inc. (AUPH) Net margin 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) net profit margin by fiscal year — reported net income divided by reported revenue.
101.5%FY2025 · since FY2018: -11464.1% → 101.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 101.5% | +99.0 pp |
| FY2024 | 2.5% | +46.9 pp |
| FY2023 | -44.4% | +36.3 pp |
| FY2022 | -80.7% | +316.2 pp |
| FY2021 | -396.9% | -192.0 pp |
| FY2020 | -204.9% | +27589.1 pp |
| FY2019 | -27794.0% | -16329.9 pp |
| FY2018 | -11464.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice